The company received three complaints about patients who had perforation injuries linked to the devices.

Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED ...

We recap the year's biggest executive hirings, promotions and departures at Medtronic, J&J MedTech, Intuitive and other ...

With the Own It effort, Medtronic is providing a way for those living with diabetes to celebrate ordinary moments made possible with the right technology so they can own every choice.

Goldman Sachs, BofA Securities, Citigroup and Morgan Stanley are the ​lead underwriters for the IPO. MiniMed, which has tapped more than 10 underwriters for the offering, will list on the Nasdaq under ...

MiniMed has filed IPO registration with SEC as Medtronic moves forward with the spin off of its diabetes division.

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.